RESEARCHER PROFILE

Eduardo Alegría

← Back to Universidad Francisco de Vitoria

E

Universidad Francisco de Vitoria

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular HealthBlood Pressure and Hypertension StudiesAcute Myocardial Infarction ResearchCardiac Imaging and Diagnostics

Eduardo Alegría works in Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health, Blood Pressure and Hypertension Studies, Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics. Recorded institutional associations include Universidad Francisco de Vitoria.

96Publications
9,548Citations
32H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. ESC/EAS Guidelines for the management of dyslipidaemias

    2011 · 3,531 citations
  2. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

    2008 · 2,310 citations
  3. ESC/EAS Guidelines for the management of dyslipidaemias

    2011 · 709 citations
  4. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation

    2004 · 232 citations
  5. ESC/EAS Guidelines for the management of dyslipidaemias

    2011 · 192 citations
  6. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model

    2010 · 161 citations
  7. Prevalencia del síndrome metabólico en población laboral española: registro MESYAS

    2005 · 158 citations
  8. ESC/EAS Guidelines for the management of dyslipidaemias

    2011 · 154 citations
  9. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up

    2006 · 132 citations
  10. Prevalencia y características de la dislipemia en pacientes en prevención primaria y secundaria tratados con estatinas en España. Estudio DYSIS-España

    2011 · 99 citations
  11. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

    2016 · 97 citations
  12. Comparison of Serum Lipid Values in Subjects With and Without the Metabolic Syndrome

    2008 · 94 citations
  13. Usefulness of Triglycerides-to–High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

    2009 · 90 citations
  14. Prevalence of Metabolic Syndrome in the Spanish Working Population: MESYAS Registry

    2005 · 87 citations
  15. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy

    2015 · 85 citations
  16. Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Model in Rat

    2010 · 76 citations
  17. Guías de práctica clínica de la Sociedad Española de Cardiología en pruebas de esfuerzo

    2000 · 67 citations
  18. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    2021 · 67 citations
  19. Mortalidad a largo plazo y reingreso hospitalario tras infarto agudo de miocardio: un estudio de seguimiento de ocho años

    2011 · 64 citations
  20. Guía de la ESC/EAS sobre el manejo de las dislipemias

    2011 · 63 citations
  21. Long-Term Mortality and Hospital Readmission After Acute Myocardial Infarction: an Eight-Year Follow-Up Study

    2012 · 61 citations
  22. ESC/EAS Guidelines for the Management of Dyslipidaemias

    2013 · 60 citations
  23. Tendencias en factores de riesgo y tratamientos de pacientes con cardiopatía isquémica estable atendidos en consultas de cardiología entre 2006 y 2014

    2015 · 58 citations
  24. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial

    2005 · 50 citations
  25. Blood Pressure and Lipid Goal Attainment in the Hypertensive Population in the Primary Care Setting in Spain

    2007 · 47 citations

← Return to the university profile